These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 17372022)
1. TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26. Preller V; Gerber A; Wrenger S; Togni M; Marguet D; Tadje J; Lendeckel U; Röcken C; Faust J; Neubert K; Schraven B; Martin R; Ansorge S; Brocke S; Reinhold D J Immunol; 2007 Apr; 178(7):4632-40. PubMed ID: 17372022 [TBL] [Abstract][Full Text] [Related]
2. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254 [TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation. Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346 [TBL] [Abstract][Full Text] [Related]
4. CD26/DP IV in T cell activation and autoimmunity. Preller V; Gerber A; Togni M; Wrenger S; Schraven B; Röcken C; Marguet D; Ansorge S; Brocke S; Reinhold D Adv Exp Med Biol; 2006; 575():187-93. PubMed ID: 16700522 [No Abstract] [Full Text] [Related]
5. B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation. Bjarnadóttir K; Benkhoucha M; Merkler D; Weber MS; Payne NL; Bernard CCA; Molnarfi N; Lalive PH Sci Rep; 2016 Oct; 6():34594. PubMed ID: 27708418 [TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV in inflammatory CNS disease. Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S Adv Exp Med Biol; 2000; 477():145-53. PubMed ID: 10849741 [TBL] [Abstract][Full Text] [Related]
8. DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis. Reinhold D; Bank U; Täger M; Ansorge S; Wrenger S; Thielitz A; Lendeckel U; Faust J; Neubert K; Brocke S Front Biosci; 2008 Jan; 13():2356-63. PubMed ID: 17981717 [TBL] [Abstract][Full Text] [Related]
9. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325 [TBL] [Abstract][Full Text] [Related]
10. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions. Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166 [TBL] [Abstract][Full Text] [Related]
11. Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction. Yu L; Yang F; Jiang L; Chen Y; Wang K; Xu F; Wei Y; Cao X; Wang J; Cai Z Eur J Immunol; 2013 Sep; 43(9):2461-72. PubMed ID: 23716181 [TBL] [Abstract][Full Text] [Related]
12. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038 [TBL] [Abstract][Full Text] [Related]
13. Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system. Emmanouil M; Taoufik E; Tseveleki V; Vamvakas SS; Tselios T; Karin M; Lassmann H; Probert L J Immunol; 2009 Dec; 183(12):7877-89. PubMed ID: 20007573 [TBL] [Abstract][Full Text] [Related]
14. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice. Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138 [TBL] [Abstract][Full Text] [Related]
15. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis. Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108 [TBL] [Abstract][Full Text] [Related]
16. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366 [TBL] [Abstract][Full Text] [Related]
17. CD26/dipeptidyl peptidase IV in lymphocyte growth regulation. Ansorge S; Bühling F; Kähne T; Lendeckel U; Reinhold D; Täger M; Wrenger S Adv Exp Med Biol; 1997; 421():127-40. PubMed ID: 9330689 [TBL] [Abstract][Full Text] [Related]
18. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro. Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853 [TBL] [Abstract][Full Text] [Related]
19. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity. Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630 [TBL] [Abstract][Full Text] [Related]
20. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones. Reinhold D; Hemmer B; Gran B; Born I; Faust J; Neubert K; McFarland HF; Martin R; Ansorge S J Neuroimmunol; 1998 Jul; 87(1-2):203-9. PubMed ID: 9670864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]